Expert Opinion on Drug Discovery

5.0(top 5%)

impact factor

1.6K(top 10%)

papers

46.1K(top 10%)

citations

84(top 10%)

h-index

6.3(top 5%)

impact factor

2.0K

all documents

49.6K

doc citations

138(top 5%)

g-index

Top Articles

#	Title	Journal	Year	Citations
1	The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities	Expert Opinion on Drug Discovery	2015	2,907
2	Lipophilicity in drug discovery	Expert Opinion on Drug Discovery	2010	643
3	The influence of lipophilicity in drug discovery and design	Expert Opinion on Drug Discovery	2012	499
4	Virtual screening with AutoDock: theory and practice	Expert Opinion on Drug Discovery	2010	462
5	Advances in structure-based drug discovery of carbonic anhydrase inhibitors	Expert Opinion on Drug Discovery	2017	356
6	Molecular dynamics simulations and novel drug discovery	Expert Opinion on Drug Discovery	2018	292
7	Fluorescence polarization assays in small molecule screening	Expert Opinion on Drug Discovery	2011	285
8	The importance of plasma protein binding in drug discovery	Expert Opinion on Drug Discovery	2007	274
9	Ligand efficiency indices for effective drug discovery	Expert Opinion on Drug Discovery	2007	253
10	On some aspects of validation of predictive quantitative structure–activity relationship models	Expert Opinion on Drug Discovery	2007	250
11	Halogen bonding for rational drug design and new drug discovery	Expert Opinion on Drug Discovery	2012	249
12	Exploiting the hydrophobic and hydrophilic binding sites for designing carbonic anhydrase inhibitors	Expert Opinion on Drug Discovery	2013	229
13	An overview of molecular hybrids in drug discovery	Expert Opinion on Drug Discovery	2016	228
14	Gateway®recombinational cloning: a biological operating system	Expert Opinion on Drug Discovery	2007	217
15	The multicellular tumor spheroid model for high-throughput cancer drug discovery	Expert Opinion on Drug Discovery	2012	215
16	The impact of click chemistry in medicinal chemistry	Expert Opinion on Drug Discovery	2012	210
17	The transcriptional factors HIF-1 and HIF-2 and their novel inhibitors in cancer therapy	Expert Opinion on Drug Discovery	2019	204
18	Use of machine learning approaches for novel drug discovery	Expert Opinion on Drug Discovery	2016	187
19	A renaissance of neural networks in drug discovery	Expert Opinion on Drug Discovery	2016	182
20	The utilization of spirocyclic scaffolds in novel drug discovery	Expert Opinion on Drug Discovery	2016	179
21	Advances in the development of hybrid anticancer drugs	Expert Opinion on Drug Discovery	2013	177
22	Organs-on-a-chip: a new tool for drug discovery	Expert Opinion on Drug Discovery	2014	175
23	The dynamics of drug-target interactions: drug-target residence time and its impact on efficacy and safety	Expert Opinion on Drug Discovery	2010	173
24	The challenge of selecting protein kinase assays for lead discovery optimization	Expert Opinion on Drug Discovery	2008	171
25	Rodent models for Alzheimer’s disease drug discovery	Expert Opinion on Drug Discovery	2015	170
26	The structural modification of natural products for novel drug discovery	Expert Opinion on Drug Discovery	2017	169
27	Broad-spectrum coronavirus antiviral drug discovery	Expert Opinion on Drug Discovery	2019	168
28	Challenges and opportunities with drug repurposing: finding strategies to find alternative uses of therapeutics	Expert Opinion on Drug Discovery	2020	168
29	The design of semi-synthetic and synthetic glycoconjugate vaccines	Expert Opinion on Drug Discovery	2011	167
30	Promise and challenges in drug discovery and development of hybrid anticancer drugs	Expert Opinion on Drug Discovery	2009	164
31	An overview of quinoline as a privileged scaffold in cancer drug discovery	Expert Opinion on Drug Discovery	2017	164
32	Advances in computational methods to predict the biological activity of compounds	Expert Opinion on Drug Discovery	2010	163
33	In situclick chemistry: a powerful means for lead discovery	Expert Opinion on Drug Discovery	2006	159
34	An overview of molecular fingerprint similarity search in virtual screening	Expert Opinion on Drug Discovery	2016	158
35	An overview of spirooxindole as a promising scaffold for novel drug discovery	Expert Opinion on Drug Discovery	2020	157
36	Fatty acid amide hydrolase as a potential therapeutic target for the treatment of pain and CNS disorders	Expert Opinion on Drug Discovery	2009	153
37	Polyether ionophores: broad-spectrum and promising biologically active molecules for the control of drug-resistant bacteria and parasites	Expert Opinion on Drug Discovery	2009	153
38	Going further than Lipinski's rule in drug design	Expert Opinion on Drug Discovery	2012	151
39	Recent applications of click chemistry in drug discovery	Expert Opinion on Drug Discovery	2019	151
40	Rhodanine as a scaffold in drug discovery: a critical review of its biological activities and mechanisms of target modulation	Expert Opinion on Drug Discovery	2012	148
41	How to design multi-target drugs	Expert Opinion on Drug Discovery	2007	141
42	Schistosomes: challenges in compound screening	Expert Opinion on Drug Discovery	2007	140
43	Drug discovery for a new generation of covalent drugs	Expert Opinion on Drug Discovery	2012	140
44	An overview of late-stage functionalization in today’s drug discovery	Expert Opinion on Drug Discovery	2019	140
45	Using zebrafish to assess the impact of drugs on neural development and function	Expert Opinion on Drug Discovery	2009	134
46	Animal models of chronic obstructive pulmonary disease	Expert Opinion on Drug Discovery	2014	130
47	Stabilization of protein-protein interactions in drug discovery	Expert Opinion on Drug Discovery	2017	129
48	Artificial intelligence in drug discovery: recent advances and future perspectives	Expert Opinion on Drug Discovery	2021	128
49	What has virtual screening ever done for drug discovery?	Expert Opinion on Drug Discovery	2008	126
50	Advances in the structural annotation of human carbonic anhydrases and impact on future drug discovery	Expert Opinion on Drug Discovery	2019	123

Scientometrics

Overviews

Citing Bodies

Expert Opinion on Drug Discovery

Top Articles